One question on HIV prevention: Will patients take their meds?

Patients who know they're sick have trouble sticking to their medication regimens, as anyone who works to boost drug adherence knows. So, can people at risk of HIV infection be trusted to continue taking high-powered antiretrovirals to keep from getting the disease? News | Report

Suggested Articles

A suspected cancer-causing impurity that has been found in some blood pressure medicines has now shown up in Zantac and some OTC antacids.

Roche is steamrolling with Ocrevus, and to maintain that lead, its touting long-term data that show the earlier it’s given, the better patients do.

New data shows a significant reduction in relapse rates in patients taking Novartis' repurposed cancer drug ofatumumab.